New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study


Altay S., Yildirimturk O., Cakmak H. A. , Askin L., Sinan U. Y. , BEŞLİ F., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.17, no.5, pp.353-361, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.14744/anatoljcardiol.2016.7472
  • Title of Journal : ANATOLIAN JOURNAL OF CARDIOLOGY
  • Page Numbers: pp.353-361

Abstract

Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.